Histopathologic features predictive of metastasis and survival in 230 patients with cutaneous squamous cell carcinoma of the head and neck and non‐head and neck locations: a single‐center retrospective study

Background Staging systems for cutaneous squamous cell carcinoma (cSCC) produce inconsistent risk stratification. Objective The aim of this study was to identify further prognostic parameters for better stratification. Methods We retrospectively analysed the prognostic significance of clinicopatholo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2022-08, Vol.36 (8), p.1246-1255
Hauptverfasser: Farah, M., Milton, D.R., Gross, N.D., Nagarajan, P., Gu, J., Curry, J.L., Ivan, D., Torres‐Cabala, C.A., Myers, J.N., Prieto, V.G., Aung, P.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Staging systems for cutaneous squamous cell carcinoma (cSCC) produce inconsistent risk stratification. Objective The aim of this study was to identify further prognostic parameters for better stratification. Methods We retrospectively analysed the prognostic significance of clinicopathologic parameters of 230 patients who underwent primary excision of invasive cSCC of the head and neck (n = 115) and non‐head and non‐neck (n = 115) locations. In addition to known high‐risk features, we analysed tumour nest shape, invasion pattern, lymphoid response pattern and tumour budding. Results On multivariable analysis, lymphovascular invasion (LVI) and high tumour budding predicted worse disease‐specific survival, and ulceration, LVI and high tumour budding predicted worse overall survival. Only ulceration was independently associated with risk of nodal metastasis. Conclusion High tumour budding, LVI and ulceration are independently associated with poor outcome in cSCC and may be used to refine cSCC prognostic stratification, which is crucial to optimize clinical decision and to identify patients who are more likely to benefit from more aggressive interventions or clinical trials.
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.18147